VNDL
  • Home
  • Search
  • Contact
  • More
    • Methodology
    • Video Library
    • External Resources
    • FAQ
<Return to Disease List
Gangliosidosis Type 1 (GM1)​
  • Description
  • Signalment
  • Clinical Features
  • Neurolocalization
  • Genetics
<
>
Gangliosidosis is a deficiency in the enzyme beta-galactosidase which causes defects in the catabolism of gangliosides resulting in their accumulation in neuron lysosomes.
Age of Onset: 3-4 months of age
Sex Predisposition: Any sex of animal can be affected
Clinical Course:
​Clinical signs worsen over the course of several months, the condition is often lethal by 1 year of age
Clinical Signs:
Behavioral/Mental Awareness 
Seizures
Lethargy
Weight loss
 
Movement 
Ataxia
Paresis
Head tremors
 
Cranial Nerves 
Visual deficits
Brain and spinal cord
Autosomal recessive β-galactosidase (GLB1) gene mutation.

​For breed specific genetic testing, follow the link below:
https://vgl.ucdavis.edu/test/korat-gm1
To read more about this disease click below:
References
Picture
Contact us:
[email protected]

Privacy Policy
Terms and Conditions​
Disclaimer
  • Home
  • Search
  • Contact
  • More
    • Methodology
    • Video Library
    • External Resources
    • FAQ